Table 2 Outcome variables and mean values at baseline and after 48 weeks for the intervention and control groups
From: Applying the Stages of Change model to Type 2 diabetes care in Trinidad: A randomised trial
Variable | Intervention | Group | Control | Group | p- value |
|---|---|---|---|---|---|
| Â | Baseline Mean (SEM) N = 61 | At 48 weeks Mean (SEM) N = 58 | Baseline Mean (SEM) N = 61 | At 48 weeks Mean (SEM) N = 61 | Â |
HbA 1 c (%) | 8.5 (0.3) | 9.1 (0.29) | 8.2 (0.28) | 9.3 (0.29) | 0.025 |
Body Mass Index (kg/m2) | 29.1 (0.66) | 28.8 (0.68) | 27.7 (0.58) | 27.8 (0.57) | * |
Systolic BP (mmHg) | 131.6 (2.32) | 136.5 (2.43) | 133.7 (2.44) | 126.9 (1.92) | * |
Diastolic BP(mmHg) | 85.6 (1.41) | 83.4 (1.81) | 83.3 (1.2) | 82.8 (0.93) | * |
Plasma Urea (mmol/l) | 14.3 (0.74) | 15 (0.73) | 16.6 (0.89) | 16.4 (1.0) | * |
Plasma creatinine (mmol/l) | 1.0 (0.03) | 1.0 (0.02) | 1.0 (0.04) | 1.0 (0.05) | * |
Fasting Total Cholesterol (mg/dl) | 214.3 (4.91) | 214.4 (17.64) | 232.7 (6.79) | 217.2 (8.25) | * |
Fasting Total Triglycerides (mg/dl) | 156.8 (15.73) | 152.9 (10.33) | 190.7 (23.4) | 195.6 (22.87) | * |
Random glucometer value (mg/dl) | 179.2 (9.06) | 223.8 (11.12) | 170.4 (9.54) | 210.3 (7.73) | * |
Number of patients with albuminuria | 10 (NA) | 5 (NA) | 8 (NA) | 6 (NA) | Â |
Number of hypoglycemic episodes | Â | 0 | Â | 0 | Â |